骨科医疗操纵治疗预防运动疾病的初步评估
Aerospace medicine and human performance
|January 4, 2024
概括
在一项试点研究中,骨科医疗操纵技术 (OMT) 显著降低了与运动恶心相关的胃肠道和嗜睡症状. 这种非药物方法在高风险人群中有望预防运动病.
科学领域:
- 航空航天医学 航空航天医学
- 骨科治疗医学 骨科治疗医学
- 人体生理学 人体生理学
背景情况:
- 运动性疾病对军用航空安全构成重大风险,并可能导致飞行资格被取消.
- 目前用于运动性 motion sickness 的药物治疗方法受到诸如昏昏欲睡之类的副作用的限制.
研究的目的:
- 为了研究非药物干预的疗效,骨科医疗操纵技术 (OMT),以预防运动病.
- 探索OMT作为一种潜在的替代药物治疗机组人员经历运动病.
主要方法:
- 采用了一种模拟控制的,平衡的,受试者之间的研究设计.
- 参与者接受了OMT或假治疗,然后使用旋转椅进行引发运动恶心的手术.
- 使用运动疾病评估问卷 (MSAQ) 来衡量症状严重程度.
主要成果:
- 与虚假组相比,OMT组报告的胃肠道症状 (恶心) 显著减少.
- 此外,OMT组在手术后经历的睡眠相关症状 (嗜睡) 也显著减少.
- 对于周围和中心运动病症状,没有观察到组之间的显著差异.
结论:
- 初步发现表明,OMT可能有效地预防胃肠道和睡眠相关的运动恶心症状.
- 需要进一步的研究来阐明OMT效应的作用机制和持续时间.
- OMT提出了一种潜在的非药物策略,用于在运营和培训环境中预防运动病.
更多相关视频
06:18Assessing the Autonomic and Behavioral Effects of Passive Motion in Rats using Elevator Vertical Motion and Ferris-Wheel Rotation
Published on: February 7, 2020
7.5K
08:57Measuring the Influence of Magnetic Vestibular Stimulation on Nystagmus, Self-Motion Perception, and Cognitive Performance in a 7T MRT
Published on: March 3, 2023
1.9K
相关概念视频
Equilibrium and Balance
4.7K
The inner ear assumes dual functionalities of auditory perception and equilibrium maintenance. The vestibule is the organ responsible for balance. This organ contains mechanoreceptors, specifically hair cells, endowed with stereocilia, which aid in deciphering information regarding the position and motion of our heads. Two intrinsic components, the utricle and saccule, help perceive head position, while the semicircular canals track head movement. Neurological messages initiated in the...
4.7K
Cholinergic Antagonists: Therapeutic Uses
749
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
749
Pathophysiology of Vomiting
456
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
456
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
329
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
329
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
295
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
295
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
206
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
206
